Founded in 1986, Tullis Health Investors is a Palm Beach, Florida venture capital firm. They invest in the medical devices, healthcare services, healthcare infrastructure and distribution, healthcare information technology, biotechnology and pharmaceuticals sectors. Tullis Health Investors manage five funds focused on investments in North America and Asia.
Tullis Health Investors has made investments in Exagen, Estech, CareSync, OrthoSensor, Surefire Medical, BioBehavioral Diagnostics, Synageva Biopharma, Aldagen, Atritech, Impulse Monitoring and TransMolecular.
Tullis Health Investors exited their investments in Exagen, CareSync, Synageva BioPharma, Coherex Medical, Estech, Aldagen, Atritech, Myocor, Adiana, BioRexis and TransMolecular.